Equity Analysis

Quarterly Results

    Zydus Lifesciences Ltd
    Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
    BSE Code
    ISIN Demat
    Book Value()
    532321
    INE010B01027
    145.1076344
    NSE Symbol
    P/E(TTM)
    Mar.Cap( Cr.)
    ZYDUSLIFE
    35.49
    95380.92
    EPS(TTM)
    Face Value()
    Div & Yield %:
    26.71
    1
    0.64
     
Quarters
(RupeeIcon Cr)
ParticularsDec 2023Sep 2023Jun 2023
Gross Sales2225.102050.002869.90
Other Operating Income146.20109.3085.80
Other Income 106.80534.5082.40
Total Income2478.102693.803038.10
Total Expenditure 1672.201509.901814.70
PBIDT805.901183.901223.40
Interest 103.9090.9089.70
PBDT702.001093.001133.70
Depreciation127.70124.90121.20
Tax118.80171.60236.40
Fringe Benefit Tax0.000.000.00
Deferred Tax5.10-8.50-4.80
Reported Profit After Tax450.40805.00780.90
Extra-ordinary Items 0.000.000.00
Adjusted Profit After Extra-ordinary item450.40805.00780.90
EPS (Unit Curr.)4.457.967.71
EPS (Adj) (Unit Curr.)4.457.967.71
Calculated EPS (Unit Curr.)4.457.957.72
Calculated EPS (Adj) (Unit Curr.)4.457.957.72
Calculated EPS (Ann.) (Unit Curr.)17.8031.8230.87
Calculated EPS (Adj) (Ann.) (Unit Curr.)17.8031.8230.87
Book Value (Unit Curr.)0.000.000.00
Dividend (%)0.000.000.00
Equity101.20101.20101.20
Reserve & Surplus0.000.000.00
Face Value1.001.001.00
Public Shareholding (No. Of Shares)0.000.000.00
Public Shareholding (% in Equity)0.000.000.00
Pledged/Encumbered - No. of Shares0.000.000.00
Pledged/Encumbered - % in Total Promoters Holding0.000.000.00
Pledged/Encumbered - % in Total Equity0.000.000.00
Non Encumbered - No. of Shares0.000.000.00
Non Encumbered - % in Total Promoters Holding0.000.000.00
Non Encumbered - % in Total Equity0.000.000.00
PBIDTM(%)36.2257.7542.63
PBDTM(%)31.5553.3239.50
PATM(%)20.2439.2727.21
Dividend Per Share(Rs)0.000.000.00
Diluted EPS4.457.967.71